NTI | bio,
partnering with experts from around the world, launched the NTI
Biosecurity Innovation and Risk Reduction Initiative in Cambridge, Massachusetts on
October 29. The multi-year project seeks to identify, develop, publicize, and
promote concrete and normative actions to reduce global catastrophic biological
risks associated with advances in technology.
“It is
imperative to recognize both the important benefits and the risks associated
with advances in biotechnology,” said NTI Co-Chair and CEO Ernest J. Moniz. “This
initiative engages the global technical community to develop concrete actions
now that allow us to reduce the risk of accidental or deliberate misuse and
create new opportunities for biosecurity innovation.”
Participants
included global leaders in the related fields of genomics, virology, microbiology,
security, bioethics, research funding, and science publishing.
Recognizing
that advances in biotechnology are rapidly outpacing the ability of governments
to provide effective oversight, Initiative participants–including leading
technical experts and organizations such as Wellcome Trust, the World Economic
Forum, and the World Health Organization—discussed the vision and actions that
would guide the effort and agreed to take forward specific proposals for researchers,
institutions, companies, and investors to reduce risks. The proposals include incentives and new mechanisms
for the technical community and the private sector to prevent misuse and
promote a safer, more secure pursuit of biotechnology innovation to benefit
society. Among them:
In
2019, NTI and its partners will organize working groups composed of Initiative
members and other subject-matter experts to further refine proposed new actions,
consider pilot projects to demonstrate their feasibility, and develop
strategies for widespread adoption.
This
NTI effort is made possible through generous support from the Open Philanthropy Project.
About the Nuclear Threat Initiative
The Nuclear Threat Initiative works to
protect our lives, environment, and quality of life now and for future
generations. We work to prevent catastrophic attacks with weapons of mass
destruction and disruption (WMDD)—nuclear, biological, radiological, chemical,
and cyber.
Sign up for our newsletter to get the latest on nuclear and biological threats.
A new NTI | bio report describes the status of benchtop DNA synthesis devices, explains the risks for biosecurity, and recommends action and oversight by governments, industry, and the scientific community.
NTI | bio partnered with Carnegie India as a "knowledge partner" for the 2022 Global Technology Summit and led two sessions on global biosecurity and biosafety.
NTI announces Dr. Piers Millett as the founding executive director of IBBIS, a new global biosecurity organization.
